Chemotherapy for gastric cancer

doi:10.3748/wjg.v12.i2.204

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 2

This Article

(0)

(6125)

(76)

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Review

World J Gastroenterol. Jan 14, 2006; 12(2): 204-213
Published online Jan 14, 2006. doi: 10.3748/wjg.v12.i2.204

Table 4 Phase II studies of preoperative chemotherapy in localized gastric cancer

Author.^Year	Number of patients	Neoadjuvant chemotherapy regimen	Adjuvant chemotherapy regimen	R0 rate	_PCR	Median survival (mo)	2-yr survival rate (%)
Wilke.¹⁹⁸⁹	34	EAP × 2	EAP × 2	29	5	18	26
Leichman.¹⁹⁹²	38	CF ×2	Intraperitoneal	76	3	17	NR
Ajani.¹⁹⁹³	48	EAP × 3	EAP × 2	77	0	16	42
Kang.¹⁹⁹⁶	53	EFP ×2-3	EFP × 3-6	71	4	43	NR
	54	Surgery	None	61		30	NR
Crookes.¹⁹⁹⁷	59	CF ×2	Intraperitoneal	71	5	48	64
Songun.¹⁹⁹⁹	27	FAMtx × 4	None	56	0	36	62
	29	Surgery	None	62		13.1	NR

EAP: etoposide, doxorubicin and cisplatin; CF: cisplatin and 5-fluoruracil; EFP: etoposide, 5-fluouracil and cisplatin; FAMtx: 5-fluoruracil, doxorubicin and methotrexate; pCR: pathological complete remission; NR: no reported

Full Size Table

Citation: Sastre J, García-Saenz JA, Díaz-Rubio E. Chemotherapy for gastric cancer. World J Gastroenterol 2006; 12(2): 204-213
URL: https://www.wjgnet.com/1007-9327/full/v12/i2/204.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i2.204

Sastre J, García-Saenz JA, Díaz-Rubio E. Chemotherapy for gastric cancer. World J Gastroenterol 2006; 12(2): 204-213 [PMID: 16482619 DOI: 10.3748/wjg.v12.i2.204]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.